Topic

Active Surveillance

Fillmore and his collaborators have investigated the implementation and diagnostic accuracy of active surveillance for patients with favorable-risk prostate cancer. His research demonstrates that magnetic resonance imaging lacks sufficient negative predictive value to reliably rule out higher-grade disease, indicating that imaging cannot currently replace confirmatory biopsies. These findings emphasize the necessity of histological verification to avoid the underdiagnosis of clinically significant prostate cancer during surveillance.

Clinical Oncology 2 Confirmatory Biopsy 2 Electronic Health Records 2 Prostate Cancer 2 Race and Ethnicity 2 Retrospective Cohort Study 2 U.S. Veterans and VA Data 2 Age Factors 1 Area Deprivation Index 1 Clinical Practice Diffusion 1 Epidemiology 1 Logistic Regression 1

Publications (2)

2026

Active Surveillance Use for Favorable-Risk Prostate Cancer in a Veterans Affairs Population.

Grace Lee^†, John R. Bihn^†, John M. Culnan, Jennifer La, Nhan V. Do, Kenute Myrie, Channing J. Paller, Nathanael R. Fillmore^‡, Matthew R. Cooperberg^‡, PROFOUND-VET Investigators^† Equal first authorship · ^‡ Equal senior authorship

JAMA

Active Surveillance Age Factors Area Deprivation Index Clinical Oncology Clinical Practice Diffusion

2026

Magnetic Resonance Imaging or Confirmatory Biopsy for Patients With Prostate Cancer Receiving Active Surveillance.

Matthew R. Cooperberg^†, John R. Bihn^†, John M. Culnan, Jennifer La, Sergey D. Goryachev, Daniel C. R. Chen, Oleg Soloviev, Grace Lee, June K. Corrigan, Kaitlin N. Swinnerton, Nicholas G. Nickols, Karlynn N. Dulberger, Pedro Barata, Rhonda L. Bitting, Mary T. Brophy, Heather H. Cheng, Hoedt Amanda De, Nhan V. Do, Stephen J. Freedland, Isla P. Garraway, J. Michael Gaziano, Susan Halabi, Richard L. Hauger, Stacy Loeb, David M. Nanus, Timothy R. Rebbeck, Matthew B. Rettig, Chong-Xian Pan, Kenute Myrie, Rachel B. Ramoni, Nathanael R. Fillmore^‡, Channing J. Paller^‡^† Equal first authorship · ^‡ Equal senior authorship

JAMA Oncology12(1), 111-113

U.S. Veterans and VA Data Retrospective Cohort Study Electronic Health Records Prostate Cancer Active Surveillance